Peer-led Group Intervention for Coping With Disaster
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03907995 |
|
Recruitment Status :
Completed
First Posted : April 9, 2019
Last Update Posted : May 27, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Anxiety Disorder PTSD Depressive Symptoms Anger Depressive Disorder | Behavioral: Cognitive Behavioral Therapy | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 18 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Peer-led Group Intervention for Coping With Disaster |
| Actual Study Start Date : | May 29, 2019 |
| Actual Primary Completion Date : | December 31, 2019 |
| Actual Study Completion Date : | December 31, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Cognitive Behavioral Therapy
The form of treatment will involve 6 group sessions every two weeks about an hour each. Sessions consist of teaching a different coping technique in each session to help cope with disaster or other events.
|
Behavioral: Cognitive Behavioral Therapy
The form of treatment will involve 6 group sessions every two weeks about an hour each. Sessions consist of teaching a different coping technique in each session to help cope with disaster or other events.
Other Names:
|
- PTSD Symptom Scale - Adult [ Time Frame: Post-treatment, which is 12 weeks after baseline. ]The PTSD Symptom Scale - Self Report is a 17-item, Likert-scale, self-report questionnaire designed to assess the symptoms of PTSD according to DSM-IV. Each of the 17 items is rated on a scale from 0 to 3, with total score ranging from 0 to 51 by adding them up.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 18 years and older and English speaking.
Exclusion Criteria:
- Individuals under the age of 18 and non-English speaking and participants who do not wish to participate in this study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03907995
| United States, Texas | |
| Baylor College of Medicine: Jamail Specialty Care Center | |
| Houston, Texas, United States, 77030 | |
| Principal Investigator: | Eric Storch, Ph.D. | Baylor College of Medicine |
| Responsible Party: | Eric Alan Storch, Professor, Baylor College of Medicine |
| ClinicalTrials.gov Identifier: | NCT03907995 |
| Other Study ID Numbers: |
H-44353 |
| First Posted: | April 9, 2019 Key Record Dates |
| Last Update Posted: | May 27, 2020 |
| Last Verified: | May 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Disease Depressive Disorder Depression Anxiety Disorders |
Pathologic Processes Mood Disorders Mental Disorders Behavioral Symptoms |

